EUVIMEDEUVIMED entdecken
Fallbericht

Severe symptomatic hypocalcemia and prolonged heart failure after treatment of osteoporosis with denosumab in a peritoneal dialysis patient: A case report

Keisuke Yoshida iD, Shigeki Kojima iD, Tsutomu Sakurada iD

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2026-07 · 46 (4) · 396-399

DOI: 10.1177/08968608251361322 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, online erschienen am 23.07.2025. Verfasst von Keisuke Yoshida und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan. Hauptthemen laut MEDLINE: Denosumab, Hypocalcemia, Heart Failure, Peritoneal Dialysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with dialysis have a high risk of osteoporosis and fractures. However, the optimal treatment strategies for osteoporosis in dialysis patients remain unclear due to the complexity of chronic kidney disease (CKD)–mineral and bone disorder. This case report describes severe symptomatic hypocalcemia and prolonged heart failure following denosumab treatment in a peritoneal dialysis (PD) patient with secondary hyperparathyroidism and osteoporosis. A 70-year-old woman on PD for dialysis caused by diabetic nephropathy was diagnosed with osteoporosis (T score −2.5) during a routine checkup. Denosumab, a receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitor, was administered following an increase in active vitamin D analog levels. One month later, she developed tetany, making it difficult to perform PD. Two days later, she was hospitalized with breathing difficulties and diagnosed with severe hypocalcemia and heart failure. Heart failure was attributed to mild fluid overload and reduced cardiac contractility due to hypocalcemia. Treatment with calcium supplementation and hemodialysis alleviated her symptoms and improved cardiac function. Denosumab is a promising option for osteoporosis in dialysis patients, but it poses a significant risk of severe hypocalcemia, especially in those with secondary hyperparathyroidism. Reports of such complications in PD patients are rare. Clinicians should carefully monitor serum calcium levels, implement preventive strategies, and promptly address complications when using denosumab in this population. In this case, cardiac function remained impaired for at least 6 months, suggesting prolonged heart failure following denosumab-associated hypocalcemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabHypocalcemiaHeart FailurePeritoneal DialysisOsteoporosisBone Density Conservation AgentsKidney Failure, ChronicHumansFemaleAgedHyperparathyroidism, Secondary

Stichwörter der Autor:innen

denosumabperitoneal dialysisprolonged heart failuresevere hypocalcemia

Substanzen

DenosumabBone Density Conservation Agents

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

ORCID-Profile: Keisuke Yoshida, Shigeki Kojima, Tsutomu Sakurada

Zitieren

APA

Yoshida, K., Kojima, S., & Sakurada, T. (2026). Severe symptomatic hypocalcemia and prolonged heart failure after treatment of osteoporosis with denosumab in a peritoneal dialysis patient: A case report. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 46(4), 396-399. https://doi.org/10.1177/08968608251361322

Vancouver

Yoshida K, Kojima S, Sakurada T. Severe symptomatic hypocalcemia and prolonged heart failure after treatment of osteoporosis with denosumab in a peritoneal dialysis patient: A case report. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2026;46(4):396-399. doi:10.1177/08968608251361322

BibTeX
@article{Yoshida2026,
  author = {Yoshida, Keisuke and Kojima, Shigeki and Sakurada, Tsutomu},
  title = {Severe symptomatic hypocalcemia and prolonged heart failure after treatment of osteoporosis with denosumab in a peritoneal dialysis patient: A case report},
  journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {396--399},
  doi = {10.1177/08968608251361322}
}
Kostenlos starten →